Category Archives: Patently BIOtech

BIO IP News Weekly for March 20, 2009

BIO’s weekly newsletter of stories compiled from a variety of public news sources, previously only available to BIO members, is now publicly available: See our temporary version here to check out the news we’re following for March 20, 2009.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags:

US Court of Appeals for the Federal Circuit Issues Decision in Tafas v Dudas

Read the Decision here: http://tinyurl.com/ce6o7r Read BIO’s Comments to the US Patent and Trademark Office on Proposed Rule Changes Concerning Claims Containing Alternative Language: http://www.bio.org/ip/domestic/20071009.pdf

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

Monsanto Company: “Protect Innovation”

Read Monsanto Company’s guest blog post on innovation and patent reform on Patently-O Blog.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags:

HHS Requests Public Comment on Draft Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests

HHS Requests Public Comment on Draft Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests.

Patently BIOtech  |  Leave a comment  |  Email This Post

Burrill Report’s interview with BIO’s President & CEO

Check out the new podcast on patent reform from Danny Levine of Burrill & Company at the Burrill Report blog.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: